CellChat analysis elucidated the differential expression of chemokines in keratitis. After that, screening amebic nano-antibodies, synthesizing antibody-chemokine fusion proteins, and validated their ...

Credit: Dalin Ou via Getty Images. US biotech Merida Biosciences has launched with $121m in Series A financing to develop therapeutics targeting disease-causing antibodies in autoimmune diseases and ...

Rallybio ends RLYB212 trial for FNAIT; shifts focus to RLYB116 and preclinical assets with 2025 trial milestones and $6 billion market potential.

Apri 7, 2025 — Researchers from Lawrence Livermore National Laboratory (LLNL), in collaboration with other institutions, have successfully used an AI-driven platform to preemptively optimize an ...

Division of Physical Biology, CAS Key Laboratory of Interfacial Physics and Technology, Shanghai Institute of Applied Physics, Chinese Academy of Sciences, Shanghai 201800, China University of Chinese ...

An international team led by Rutgers University-New Brunswick researchers has merged two lab-synthesized materials into a synthetic quantum structure once thought impossible to exist and produced ...

RhoGAM almost completely prevents this. If an Rh-negative person is pregnant with an Rh-positive fetus, there is a risk that the parent could develop antibodies against Rh-positive red blood cells if ...

Spanish scientists documented a second so-called class switch in people with "repeated" mRNA COVID jabs, meaning their bodies start churning out two kinds of antibodies that learn to live with ...

BioAtla is laying off 30% of staff as the biotech searches for partners for some of its conditionally active biologic (CAB) antibodies while eking out its cash to cover a slew of clinical readouts ...

But promising results from a recent clinical trial suggest that broadly neutralizing antibody therapy (bNAbs) may be able to accomplish the next best thing. Data from the trial—a collaboration ...